Swiss National Bank’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,407
| Closed | -$333K | – | 2791 |
|
|
2022
Q1 | $333K | Buy |
3,407
+258
| +8% | +$33.1K | ﹤0.01% | 2651 |
|
|
2021
Q4 | $515K | Hold |
3,149
| – | – | ﹤0.01% | 2660 |
|
|
2021
Q3 | $860K | Hold |
3,149
| – | – | ﹤0.01% | 2477 |
|
|
2021
Q2 | $1.25M | Sell |
3,149
-115
| -4% | -$53.7K | ﹤0.01% | 2375 |
|
|
2021
Q1 | $1.76M | Buy |
3,264
+27
| +0.8% | +$16.8K | ﹤0.01% | 2078 |
|
|
2020
Q4 | $1.22M | Hold |
3,237
| – | – | ﹤0.01% | 2191 |
|
|
2020
Q3 | $1.22M | Buy |
3,237
+129
| +4% | +$57K | ﹤0.01% | 1982 |
|
|
2020
Q2 | $1.53M | Buy |
3,108
+408
| +15% | +$182K | ﹤0.01% | 1861 |
|
|
2020
Q1 | $992K | Buy |
2,700
+937
| +53% | +$485K | ﹤0.01% | 1831 |
|
|
2019
Q4 | $1.25M | Buy |
1,763
+37
| +2% | +$25.5K | ﹤0.01% | 2020 |
|
|
2019
Q3 | $1.11M | Buy |
1,726
+27
| +2% | +$21.4K | ﹤0.01% | 2005 |
|
|
2019
Q2 | $1.49M | Buy |
1,699
+178
| +12% | +$122K | ﹤0.01% | 1884 |
|
|
2019
Q1 | $879K | Hold |
1,521
| – | – | ﹤0.01% | 2134 |
|
|
2018
Q4 | $427K | Buy |
1,521
+62
| +4% | +$24.5K | ﹤0.01% | 2406 |
|
|
2018
Q3 | $701K | Hold |
1,459
| – | – | ﹤0.01% | 2312 |
|
|
2018
Q2 | $661K | Hold |
1,459
| – | – | ﹤0.01% | 2365 |
|
|
2018
Q1 | $858K | Hold |
1,459
| – | – | ﹤0.01% | 2159 |
|
|
2017
Q4 | $906K | Hold |
1,459
| – | – | ﹤0.01% | 2143 |
|
|
2017
Q3 | $1.34M | Hold |
1,459
| – | – | ﹤0.01% | 1875 |
|
|
2017
Q2 | $1.36M | Buy |
1,459
+256
| +21% | +$251K | ﹤0.01% | 1835 |
|
|
2017
Q1 | $1.14M | Hold |
1,203
| – | – | ﹤0.01% | 1939 |
|
|
2016
Q4 | $965K | Hold |
1,203
| – | – | ﹤0.01% | 2062 |
|
|
2016
Q3 | $1.02M | Hold |
1,203
| – | – | ﹤0.01% | 1953 |
|
|
2016
Q2 | $991K | Sell |
1,203
-96
| -7% | -$105K | ﹤0.01% | 1970 |
|
|
2016
Q1 | $1.4M | Buy |
1,299
+238
| +22% | +$244K | ﹤0.01% | 1686 |
|
|
2015
Q4 | $1.32M | Buy |
1,061
+23
| +2% | +$38K | ﹤0.01% | 1610 |
|
|
2015
Q3 | $1.4M | Buy |
1,038
+201
| +24% | +$332K | ﹤0.01% | 1543 |
|
|
2015
Q2 | $1.51M | Buy |
837
+103
| +14% | +$160K | ﹤0.01% | 1524 |
|
|
2015
Q1 | $1.19M | Buy |
734
+62
| +9% | +$91.9K | ﹤0.01% | 1673 |
|
|
2014
Q4 | $511K | Buy |
672
+35
| +5% | +$18.6K | ﹤0.01% | 2163 |
|
|
2014
Q3 | $252K | Hold |
637
| – | – | ﹤0.01% | 2384 |
|
|
2014
Q2 | $385K | Hold |
637
| – | – | ﹤0.01% | 2295 |
|
|
2014
Q1 | $438K | Buy |
637
+107
| +20% | +$71.7K | ﹤0.01% | 2191 |
|
|
2013
Q4 | $345K | Buy |
+530
| New | +$316K | ﹤0.01% | 2206 |
|
Other funds holding TCRT
MP
DCM
LCM
Swiss National Bank's TCRT Position: Q2 2022 in Review
Swiss National Bank sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 3,407 shares — an estimated $333K sold.
Swiss National Bank first reported a position in TCRT in Q4 2013 and held it in 34 quarters. The position peaked at $1.76M in Q1 2021. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.
- Swiss National Bank reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
- Swiss National Bank sold 3,407 Alaunos Therapeutics shares in Q2 2022, an estimated $333K.
- Swiss National Bank first reported a position in Alaunos Therapeutics in Q4 2013 and held it in 34 quarters.
- Swiss National Bank's Alaunos Therapeutics position peaked at $1.76M in Q1 2021.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.
Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.